Mortality in isodicentric chromosome 15 syndrome: The role of SUDEP

2016 ◽  
Vol 61 ◽  
pp. 1-5 ◽  
Author(s):  
Daniel Friedman ◽  
Alison Thaler ◽  
Jonathan Thaler ◽  
Samhitha Rai ◽  
Edwin Cook ◽  
...  
2021 ◽  
Vol 14 (1) ◽  
Author(s):  
Tesshu Hori ◽  
Shohei Ikuta ◽  
Satoko Hattori ◽  
Keizo Takao ◽  
Tsuyoshi Miyakawa ◽  
...  

AbstractThe 15q13.3 microdeletion syndrome is a genetic disorder characterized by a wide spectrum of psychiatric disorders that is caused by the deletion of a region containing 7 genes on chromosome 15 (MTMR10, FAN1, TRPM1, MIR211, KLF13, OTUD7A, and CHRNA7). The contribution of each gene in this syndrome has been studied using mutant mouse models, but no single mouse model recapitulates the whole spectrum of human 15q13.3 microdeletion syndrome. The behavior of Trpm1−/− mice has not been investigated in relation to 15q13.3 microdeletion syndrome due to the visual impairment in these mice, which may confound the results of behavioral tests involving vision. We were able to perform a comprehensive behavioral test battery using Trpm1 null mutant mice to investigate the role of Trpm1, which is thought to be expressed solely in the retina, in the central nervous system and to examine the relationship between TRPM1 and 15q13.3 microdeletion syndrome. Our data demonstrate that Trpm1−/− mice exhibit abnormal behaviors that may explain some phenotypes of 15q13.3 microdeletion syndrome, including reduced anxiety-like behavior, abnormal social interaction, attenuated fear memory, and the most prominent phenotype of Trpm1 mutant mice, hyperactivity. While the ON visual transduction pathway is impaired in Trpm1−/− mice, we did not detect compensatory high sensitivities for other sensory modalities. The pathway for visual impairment is the same between Trpm1−/− mice and mGluR6−/− mice, but hyperlocomotor activity has not been reported in mGluR6−/− mice. These data suggest that the phenotype of Trpm1−/− mice extends beyond that expected from visual impairment alone. Here, we provide the first evidence associating TRPM1 with impairment of cognitive function similar to that observed in phenotypes of 15q13.3 microdeletion syndrome.


2017 ◽  
Vol 2017 ◽  
pp. 1-6 ◽  
Author(s):  
Elliott J. Carande ◽  
Samuel J. Bilton ◽  
Satish Adwani

Neonatal Marfan syndrome (nMFS) is a rare condition with a poor prognosis. It is genotypically and phenotypically distinct from the typical Marfan syndrome and carries a poorer prognosis. This case report describes the progression of a 14-month-old girl diagnosed with nMFS at 5 months of age. Her diagnosis followed the identification of a fibrillin-1 mutation (FBN1gene, exon 26, chromosome 15), which is a common locus of nMFS. This patient developed severe cardiac complications resulting in congestive cardiac failure in early life and required major cardiac surgery. Since surgical intervention, our patient is still reliant on a degree of ventilator support, but the patient has gained weight and echocardiography has demonstrated improved left ventricular function and improved tricuspid and mitral valve regurgitation. Therefore, we argue the importance of a cautious multidisciplinary approach to early surgical intervention in cases of nMFS.


2019 ◽  
Vol 4 (3) ◽  

APS syndrome is a skin-related genetic disorder characterized by painless skin lesions from the upper layer of the skin. In addition to the above, sometimes peeling of the skin in the arms and legs also occurs. Skin peeling usually appears at birth, but can begin in childhood or later in life. APS syndrome is caused by the mutation of the TGM5 gene, which is based on the long arm of chromosome 15 as 15q15.2.


2012 ◽  
Vol 55 (12) ◽  
pp. 487 ◽  
Author(s):  
Jon Soo Kim ◽  
Jinyu Park ◽  
Byung-Joo Min ◽  
Sun Kyung Oh ◽  
Jin Sun Choi ◽  
...  

2014 ◽  
Vol 40 (6) ◽  
pp. 1795-1798 ◽  
Author(s):  
Taro Nonaka ◽  
Izumi Ooki ◽  
Takayuki Enomoto ◽  
Koichi Takakuwa

2005 ◽  
Vol 7 (1) ◽  
pp. 17-29

Biological traits that are predictive of the later development of psychosis have not yet been identified. The complex, multidetermined nature of schizophrenia and other psychoses makes it unlikely that any single biomarker will be both sensitive and specific enough to unambiguously identify individuals who will later become psychotic. However, current genetic research has begun to identify genes associated with schizophrenia, some of which have phenotypes that appear early in life. While these phenotypes have low predictive power for identifying individuals who will become psychotic, they do serve as biomarkers for pathophysiological processes that can become the targets of prevention strategies. Examples are given from work on the role of the alpha(T)nicotinic receptor and its gene CHRNA7 on chromosome 15 in the neurobiology and genetic transmission of schizophrenia.


1981 ◽  
Vol 28 (6) ◽  
pp. 785-798 ◽  
Author(s):  
Jack Spira ◽  
Francis Wiener ◽  
Magda Babonits ◽  
Jenny Gamble ◽  
Jacques Miller ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document